# HDT Bio funding: rounds and investors

> HDT Bio has raised $6.2M across 2 rounds since 2023. Investors include National Institutes of Health and National Institute of Allergy and Infectious Diseases.

Source: https://millionrounds.com/company/hdt-bio (Millionrounds; every figure on the page links to its filing or article)

United States · [Funded startup](https://millionrounds.com/companies)

# Who invested in *HDT Bio*

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 2 months ago

Funding summary Updated 26 Oct 2026

**$6.2M** raised across 2 rounds since 2023, from 2 sources

**$1.0M** Grant **$5.2M** Grant

- **Latest round:** Grant, $5.2M Sept 2026
- **Step-up i:** 5.2×
- **Investors:** 2

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2024 2025 2026

**$1.0M** Grant

**$5.2M** Grant

- **First round:** Grant, $1.0M
- **Biggest round:** $5.2M
- **Between rounds:** 2.9 years

## The rounds

- **Sept 2026** Grant **$5.2M** *2 returning* [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) [National Institute of Allergy and Infectious Diseases](https://millionrounds.com/fund/national-institute-of-allergy-and-infectious-diseases) Source recorded
- **Oct 2023** Grant **$1.0M** *2 new* [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) [National Institute of Allergy and Infectious Diseases](https://millionrounds.com/fund/national-institute-of-allergy-and-infectious-diseases) Source recorded

## Founders and team

From HDT Bio's own website: 1 founder, 21 on the team.

**Steve Reed** Co-Founder & CEO

- **Loren Beck** Chief Legal Officer
- **Peter Berglund** Chief Development Officer
- **Allie Lafferty** Research Associate II
- **Alyse Douglass** Research Associate III
- **Brian Granger** Senior Research Associate
- **Carrie Novák** Associate Scientist
- **Heather Kain** Research Associate III
- **Ira Coleman** Director
- **James Keary** Senior Clinical Trial Manager
- **Jannabeth Bannister** Senior Funding Manager
- **Jim Reed** Senior Scientist
- **John Ballantyne** Director
- **Kelli Carabello** Senior Director, Finance & Accounting
- **Kiara Hatzakis** Research Associate II
- **Priyanka Kamath** Senior Program Manager
- **Satoko Yamaoka** Senior Scientist
- **Scott Delbecq** Senior Scientist
- **Shibbu Sharma** Research Associate III

And 3 more on the team.

Advisers *Darrick Carter*

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Grant** 2023 **Grant** 2026 [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) [National Institute of Allergy and Infectious Diseases](https://millionrounds.com/fund/national-institute-of-allergy-and-infectious-diseases)

## Everyone who backed them

[National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) Government **2** rounds

[National Institute of Allergy and Infectious Diseases](https://millionrounds.com/fund/national-institute-of-allergy-and-infectious-diseases) Investment firm **2** rounds

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=hdt-bio).

## Quick answers about HDT Bio

### Who invested in HDT Bio?

HDT Bio's investors include National Institutes of Health and National Institute of Allergy and Infectious Diseases.

### How much has HDT Bio raised?

HDT Bio has raised $6.2M across 2 rounds since 2023.

### When did HDT Bio last raise?

HDT Bio's most recent round was a Grant of $5.2M in Sept 2026.

### What was HDT Bio's biggest round?

Its most recent round, $5.2M in Sept 2026, is also its largest on record.

### Who backed HDT Bio first?

HDT Bio's first round on record, in Oct 2023, was backed by National Institutes of Health and National Institute of Allergy and Infectious Diseases.

### What stage is HDT Bio at?

HDT Bio's latest named round is a Grant, in Sept 2026.

### Where is HDT Bio based?

HDT Bio is based in the United States.

## Companies like HDT Bio

In the same sector, and raised in the last eighteen months.

[**Matchpoint Therapeutics** $220M · Oct 2026](https://millionrounds.com/company/matchpoint-therapeutics)[**Rx Bandz** Oct 2026](https://millionrounds.com/company/rx-bandz)[**Hera Biotech** $1.8M · Sept 2026](https://millionrounds.com/company/hera-biotech)[**GevRx Nutraceuticals** $300K · Sept 2026](https://millionrounds.com/company/gevrx-nutraceuticals)[**RegCell** $81M · Sept 2026](https://millionrounds.com/company/regcell)[**ClearSight Therapeutics** $307K · Sept 2026](https://millionrounds.com/company/clearsight-therapeutics)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app